OBD
is an England-based biotechnology company that researches and develops epigenetic biomarkers for the treatment of cancer and other diseases... Read moreOBD
is an England-based biotechnology company that researches and develops epigenetic biomarkers for the treatment of cancer and other diseases... Read more
News
Jun 30, 2026
Marketscreener
OBD: Oxford BioDynamics Plc Reports Earnings Results for the Half Year Ended March 31, 2026
Jun 30, 2026
Marketscreener
OBD: Oxford BioDynamics Plc Announces Appointment of Richard Compton as Chief Executive Officer, Effective June 30, 2026
Dec 16, 2025
Marketscreener
OBD: Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2025
Oct 13, 2025
Proactive Investors
OBD: Oxford BioDynamics' Bartu Ahiska on breakthrough CFS test
Sep 04, 2025
Sharecast
OBD: Oxford Biodynamics jumps on interim findings from ongoing CiRT trial
Aug 22, 2025
Proactive Investors
OBD: Oxford BioDynamics partners with Google Cloud
Jun 30, 2025
Marketscreener
OBD: Oxford BioDynamics Plc Reports Earnings Results for the Half Year Ended March 31, 2025
May 09, 2025
Sharecast
OBD: Oxford BioDynamics gets UK lab accredited as clinical facility
Mar 13, 2025
Marketscreener
OBD: Oxford BioDynamics expands UK insurance partnership with Bupa
Feb 28, 2025
Marketscreener
OBD: Oxford Biodynamics shares dive as loss widens despite revenue rise
OBD Competitors
1
2
3
4
5
6
7
8
9
10